FINASTERIDE TABLETS

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D224R0001

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents2
The Defense Logistics Agency (DLA) Troop Support has issued a solicitation, identified as SPE2D224R0001, for the procurement of Finasteride Tablets. This opportunity falls under the North American Industry Classification System (NAICS) code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code (PSC) 6505, indicating a focus on pharmaceuticals and drugs. The primary objective of this procurement is to secure a reliable supply of Finasteride Tablets for federal use, ensuring that the agency’s pharmaceutical requirements are met in a timely and consistent manner. The scope of the solicitation likely encompasses the manufacturing, packaging, and delivery of Finasteride Tablets in accordance with federal standards and specifications, although specific quantities, packaging requirements, and delivery schedules are not detailed in the provided notice. DLA Troop Support, a federal office responsible for providing medical and pharmaceutical supplies to military and federal entities, is the contracting authority for this solicitation. The agency is seeking qualified manufacturers or suppliers with the capability to produce pharmaceutical-grade Finasteride Tablets that comply with all applicable regulatory and quality standards. Interested contractors should note that the solicitation was posted on April 3, 2024, and the response deadline was set for the same day, indicating a rapid procurement process or a possible amendment to the timeline. The notice is currently marked as inactive, suggesting that the response period has closed or the requirement has been fulfilled. For further information or clarification regarding the solicitation, potential offerors were directed to contact Syerita Avant ([email protected], 215-737-8370) as the primary point of contact, or Jason Wray ([email protected], 215-737-0614) as the secondary contact. No specific set-aside requirements, such as small business or socio-economic preferences, are mentioned in the notice. Additionally, there are no details provided regarding contract type, period of performance, evaluation criteria, or special considerations such as quality assurance provisions or delivery locations. Contractors interested in opportunities of this nature should ensure they are registered under the appropriate NAICS and PSC codes and are capable of meeting stringent federal pharmaceutical manufacturing and supply standards. Further details, including solicitation attachments, can be accessed via the official SAM.gov opportunity page at https://sam.gov/opp/8b0feab262ce4307a0837e5abbdffc98/view. In summary, this solicitation represents a federal requirement for the supply of Finasteride Tablets, managed by DLA Troop Support, and is best suited for established pharmaceutical manufacturers with experience in federal contracting and compliance with regulatory standards.